Technologies developed at UT Southwestern Medical Center can be commercialized through either direct licensing to an existing corporation or through licensing to a new company (a start-up).
The Technology Commercialization group is charged with developing start-up companies. This activity benefits the University directly through the ownership of equity and other license derived compensation, and indirectly through the advantages to University researchers and the community and increased University-industry relations.
The group actively seeks out UT Southwestern technologies suitable for entrepreneurial venture development and participates in the development of new companies based on those technologies.
Technology Commercialization projects benefit from the accumulated experience of the staff, who have managed licensing activities for more than 35 start-ups for pharmaceutical, biomedical, and medical device technologies invented by UT Southwestern researchers.
The strategy for UT Southwestern's technology commercialization is not to measure success by the total number of start-ups incorporated. Rather, it is focused on the establishment of robust entities that have substantial technologies, experienced management, and adequate funding to achieve their strategic goals and build value for the equity holders, which includes the University and inventors.
In some cases the Technology Commercialization group has combined multiple UT Southwestern technologies into a single diversified portfolio company, rather than forming multiple small start-ups.
For more information, contact Technology Development at email@example.com or call 214-648-1908.